Free Trial

McKesson (MCK) Competitors

McKesson logo
$713.71 +0.92 (+0.13%)
As of 02:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MCK vs. COR, CAH, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS

Should you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).

McKesson vs.

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cencora$638.56M88.55$1.51B$7.0341.48
McKesson$344.58B0.26$3.00B$21.8432.60

Cencora currently has a consensus price target of $290.00, suggesting a potential downside of 0.55%. McKesson has a consensus price target of $681.00, suggesting a potential downside of 4.37%. Given Cencora's higher probable upside, analysts plainly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cencora
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
McKesson
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.88

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 10.8% of Cencora shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, McKesson had 8 more articles in the media than Cencora. MarketBeat recorded 37 mentions for McKesson and 29 mentions for Cencora. Cencora's average media sentiment score of 1.46 beat McKesson's score of 1.23 indicating that Cencora is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cencora
26 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
McKesson
30 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cencora has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Cencora0.46% 328.62% 4.23%
McKesson 0.82%-181.26%5.34%

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays out 31.3% of its earnings in the form of a dividend. McKesson pays out 13.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and McKesson has increased its dividend for 17 consecutive years.

McKesson received 228 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.22% of users gave McKesson an outperform vote while only 65.21% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
CencoraOutperform Votes
748
65.21%
Underperform Votes
399
34.79%
McKessonOutperform Votes
976
74.22%
Underperform Votes
339
25.78%

Summary

McKesson beats Cencora on 13 of the 22 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCK vs. The Competition

MetricMcKessonDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$89.29B$23.03B$5.49B$18.91B
Dividend Yield0.41%1.53%5.11%4.02%
P/E Ratio32.6212.8322.5832.86
Price / Sales0.269.88397.2527.79
Price / Cash18.3812.9538.1817.52
Price / Book-33.0033.236.704.47
Net Income$3.00B$785.39M$3.23B$1.02B
7 Day Performance3.46%3.49%1.26%0.60%
1 Month Performance5.60%-2.35%3.75%-2.74%
1 Year Performance34.05%-8.35%15.78%4.48%

McKesson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.4773 of 5 stars
$713.71
+0.1%
$681.00
-4.6%
+32.7%$89.43B$344.58B32.6775,000Upcoming Earnings
Dividend Announcement
Analyst Forecast
Positive News
COR
Cencora
4.2434 of 5 stars
$286.95
+0.4%
$284.55
-0.8%
+22.5%$55.66B$638.56M40.8342,000Upcoming Earnings
Analyst Forecast
Positive News
CAH
Cardinal Health
4.4461 of 5 stars
$137.76
+0.1%
$140.86
+2.2%
+37.1%$33.29B$222.28B25.7146,500Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
Positive News
HSIC
Henry Schein
3.5418 of 5 stars
$65.35
+0.3%
$81.10
+24.1%
-6.2%$8.01B$12.67B26.9022,000Upcoming Earnings
Analyst Forecast
PDCO
Patterson Companies
3.4503 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700Analyst Forecast
Positive News
OMI
Owens & Minor
4.7128 of 5 stars
$6.79
-2.4%
$12.50
+84.2%
-71.6%$524.33M$10.70B-10.4422,500Upcoming Earnings
Short Interest ↑
HLF
Herbalife
4.5195 of 5 stars
$6.87
+2.9%
$12.00
+74.8%
-16.4%$695.71M$4.99B2.7610,100Earnings Report
Analyst Downgrade
News Coverage
Gap Down
NUS
Nu Skin Enterprises
3.8262 of 5 stars
$5.78
+0.2%
$6.88
+18.9%
-46.2%$288.44M$1.73B-1.9713,400Upcoming Earnings
COSM
Cosmos Health
2.7438 of 5 stars
$0.43
+2.1%
N/A-38.0%$11.98M$54.43M-0.18100Short Interest ↓
Positive News
HWH
HWH International
N/A$1.15
-4.5%
N/A-87.7%$7.42M$1.25M0.00N/AShort Interest ↓
MEDS
TRxADE HEALTH
N/A$0.99
+4.2%
N/A-84.2%$1.39M$7.45M0.0050News Coverage

Related Companies and Tools


This page (NYSE:MCK) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners